Purchases and Sales Made in Q3 2022 in Lineage Cell Therapeutics, Inc. (LCTX)
This table provides information about the institutional ownership of Lineage Cell Therapeutics, Inc. (LCTX) during Q3 2022. The information is specifically focused on institutions that hold shares of Lineage Cell Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Laurion Capital Management LP
New York, NY |
SELL
|
- |
-44.4K- 1.83% |
$50.2K - $78.6K
|
2.38M
$1.17M
|
|
|
Nov 14, 2022
Q3 2022
|
Lpl Financial LLC
Fort Mill, SC |
SELL
|
- |
-50K- 20.89% |
$56.5K - $88.5K
|
189K
$92.8K
|
|
|
Nov 14, 2022
Q3 2022
|
Cubist Systematic Strategies, LLC
Stamford, CT |
SELL
|
- |
-50.7K- 57.07% |
$57.2K - $89.7K
|
38.1K
$18.7K
|
|
|
Nov 14, 2022
Q3 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-51.4K- 1.37% |
$58K - $90.9K
|
3.7M
$1.82M
|
|
|
Nov 14, 2022
Q3 2022
|
Ergoteles LLC
New York, NY |
SELL
|
- |
-62.7K- 11.33% |
$70.9K - $111K
|
491K
$241K
|
|
|
Nov 10, 2022
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-64.7K- 80.7% |
$73.1K - $115K
|
15.5K
$7.58K
|
|
|
May 14, 2024
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-64.7K- 80.7% |
$73.1K - $115K
|
15.5K
$7.58K
|
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-66.3K- 51.47% |
$75K - $117K
|
62.6K
$30.7K
|
|
|
Nov 14, 2022
Q3 2022
|
Gsa Capital Partners LLP
London, X0 |
SELL
|
- |
-69.7K- 58.9% |
$78.7K - $123K
|
48.6K
$23.8K
|
|
|
Nov 10, 2022
Q3 2022
|
Phoenix Holdings Ltd.
Givatayim, L3 |
SELL
|
- |
-130K- 73.24% |
$147K - $231K
|
47.6K
$23.3K
|
|
|
Nov 14, 2022
Q3 2022
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-153K- 38.72% |
$173K - $270K
|
242K
$118K
|
|
|
Nov 14, 2022
Q3 2022
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-208K- 16.54% |
$235K - $368K
|
1.05M
$514K
|
|
|
Nov 14, 2022
Q3 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-514K- 50.38% |
$581K - $910K
|
506K
$248K
|